Redeye has a positive outlook on IRRAS sales development, but financial burdens are evident in the report. Its pressing financial situation overshadows any commercial progress at this point and needs to be sorted in order to attract interest to the stock. We adjust our fair value range, assuming an equity issue shortly.
LÄS MER